Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder
- PMID: 31495712
- DOI: 10.1016/j.bpsc.2019.07.002
Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder
Abstract
Background: The rapid-acting clinical effects of ketamine as a novel treatment for depression along with its complex pharmacology have made it a growing research area. One of the key mechanistic hypotheses for how ketamine works to alleviate depression is by enhancing long-term potentiation (LTP)-mediated neural plasticity.
Methods: The objective of this study was to investigate the plasticity hypothesis in 30 patients with depression noninvasively using visual LTP as an index of neural plasticity. In a double-blind, active placebo-controlled crossover trial, electroencephalography-based LTP was recorded approximately 3 to 4 hours following a single 0.44-mg/kg intravenous dose of ketamine or active placebo (1.7 ng/mL remifentanil) in 30 patients. Montgomery-Åsberg Depression Rating Scale scores were used to measure clinical symptoms. Visual LTP was measured as a change in the visually evoked potential following high-frequency visual stimulation. Dynamic causal modeling investigated the underlying neural architecture of visual LTP and the contribution of ketamine.
Results: Montgomery-Åsberg Depression Rating Scale scores revealed that 70% of participants experienced 50% or greater reduction in their depression symptoms within 1 day of receiving ketamine. LTP was demonstrated in the N1 (p = .00002) and P2 (p = 2.31 × 10-11) visually evoked components. Ketamine specifically enhanced P2 potentiation compared with placebo (p = .017). Dynamic causal modeling replicated the recruitment of forward and intrinsic connections for visual LTP and showed complementary effects of ketamine indicative of downstream and proplasticity modulation.
Conclusions: This study provides evidence that LTP-based neural plasticity increases within the time frame of the antidepressant effects of ketamine in humans and supports the hypothesis that changes to neural plasticity may be key to the antidepressant properties of ketamine.
Keywords: Depression; Dynamic causal modeling; Electroencephelography; Ketamine; LTP; Visually evoked potentials.
Copyright © 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errors.Eur Neuropsychopharmacol. 2020 Sep;38:73-85. doi: 10.1016/j.euroneuro.2020.07.009. Epub 2020 Aug 3. Eur Neuropsychopharmacol. 2020. PMID: 32763021 Clinical Trial.
-
Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling.Int J Neuropsychopharmacol. 2018 Aug 1;21(8):740-747. doi: 10.1093/ijnp/pyy041. Int J Neuropsychopharmacol. 2018. PMID: 29668918 Free PMC article. Clinical Trial.
-
A randomized controlled trial of intranasal ketamine in major depressive disorder.Biol Psychiatry. 2014 Dec 15;76(12):970-6. doi: 10.1016/j.biopsych.2014.03.026. Epub 2014 Apr 3. Biol Psychiatry. 2014. PMID: 24821196 Free PMC article. Clinical Trial.
-
The role of Hebbian learning in human perception: a methodological and theoretical review of the human Visual Long-Term Potentiation paradigm.Neurosci Biobehav Rev. 2020 Aug;115:220-237. doi: 10.1016/j.neubiorev.2020.03.013. Epub 2020 Jun 18. Neurosci Biobehav Rev. 2020. PMID: 32562886 Review.
-
How does ketamine elicit a rapid antidepressant response?Curr Opin Pharmacol. 2015 Feb;20:35-9. doi: 10.1016/j.coph.2014.11.005. Epub 2014 Nov 25. Curr Opin Pharmacol. 2015. PMID: 25462290 Free PMC article. Review.
Cited by
-
Immediate and long-term electrophysiological biomarkers of antidepressant-like behavioral effects after subanesthetic ketamine and medial prefrontal cortex deep brain stimulation treatment.Front Neurosci. 2024 Jun 20;18:1389096. doi: 10.3389/fnins.2024.1389096. eCollection 2024. Front Neurosci. 2024. PMID: 38966758 Free PMC article.
-
A unified model of ketamine's dissociative and psychedelic properties.J Psychopharmacol. 2023 Jan;37(1):14-32. doi: 10.1177/02698811221140011. Epub 2022 Dec 17. J Psychopharmacol. 2023. PMID: 36527355 Free PMC article. Review.
-
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).Pilot Feasibility Stud. 2023 Oct 5;9(1):169. doi: 10.1186/s40814-023-01399-8. Pilot Feasibility Stud. 2023. PMID: 37798662 Free PMC article.
-
Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.J Eat Disord. 2024 Dec 27;12(1):214. doi: 10.1186/s40337-024-01185-8. J Eat Disord. 2024. PMID: 39731144 Free PMC article. Review.
-
Ketamine for the treatment of major depression: a systematic review and meta-analysis.EClinicalMedicine. 2023 Aug 3;62:102127. doi: 10.1016/j.eclinm.2023.102127. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37593223 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical